Real-World Evidence for Treat-and-Extend Regimen of Ranibizumab Therapy for Macular Oedema Secondary to Branch Retinal Vein Occlusion

• Váldodahkkit: Carmen Antía Rodríguez-Fernández (Dahkki), Ana Campo-Gesto (Dahkki), Aida López-López (Dahkki), Mónica Gayoso-Rey (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2022-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

The aim of this study was to evaluate the efficacy of a treat-and-extend (T&E) regimen of ranibizumab as the first-choice treatment in macular oedema (MO) secondary to branch retinal vein occlusion (BRVO). We conducted a retrospective study of 20 patients who developed MO due to BRVO treated wit...